Phosphorus
Scientific References >
Phosphorus is needed for many of the chemical reactions in the body. Phosphorus compounds help regulate the release of energy that fuels our bodies. By combining with calcium, phosphorus also helps form hard, crystal-like substances that create the latticework for strong bones and teeth. In fact, 85 percent of the body's phosphorus is located in bone.
Phosphorus (symbol “P”) is found naturally in the earth’s crust as a mineral compound, commonly as apatite. It is an essential trace mineral necessary for human life. It is found in several tissues and is required for multiple enzyme systems in the human body.
Minerals for Life® Phosphorus is a liquid dietary supplement of the mineral Phosphorus
in aqueous solution as an advanced proprietary molecular delivery system. A solution yields the smallest particles the size of atoms, ions, or small molecules.
The purer the water the more efficiently minerals are activated into their electrically charged ionic state. Eniva uses OHM™ water (multi-step purified water) in a unique proprietary process at Eniva’s government-inspected manufacturing facility, yielding a bio-available form of phosphorus ions (Solutomic™) in sparkling clear solutions for quicker absorption than tablets or capsules which must first dissolve in the digestive system before being absorbed.
Minerals for Life® Phosphorus
Suggested Retail Price: $26.95
20 oz. - ID 8019
Supplement Facts |
Serving Size: 1 Teaspoon
Servings Per Container: 120 |
| |
Amount Per Serving |
% Daily Value |
Proprietary Blend |
10 mg |
|
Phosphorus |
|
<2% |
Water |
|
† |
† Daily Value no established.
Ingredients: Purified water, phosphorus (derived from sodium phosphate).
Adult Directions: 1 teaspoon.
No Artificial Colors, Flavors, or Additives
Caution: Do not consume if tamper resistant seal is broken or missing. Keep cap tightly closed and out of reach of children. Not intended for children under 14 years of age. Not for pregnant or lactating women. First consult your physician before starting this or any new mineral or nutrient supplement program. Isolated minerals or nutrients are best taken as part of a comprehensive supplement program containing a broad spectrum of nutrients. |
Minerals for Life® water-soluble Phosphorus is a dietary supplement containing elemental phosphorus.
Phosphorus is the body's source for Phosphate. Phosphate is busiest while at work in the soft tissues where it helps create and manage energy; synthesize protein, fat, and carbohydrates; and even helps contract muscles, including the beating heart. Phosphate is also essential for stimulating hormone production and creating conditions that allow the body to utilize the B vitamins. Phosphorus even helps to maintain the body's pH. Phosphorus is also a constituent of nucleic acids, the holders of genetic information for the body.
In rare cases, people who use antacids containing aluminum hydroxide for long periods of time might suffer from weakness, loss of appetite, malaise, and bone loss. This chemical apparently prevents phosphorus from being absorbed.
An excess of phosphorus is not healthy as it can upset the fine calcium-phosphorus balance and lead to bone loss.
* This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Scientific References
Adderly, B. The Complete Guide to Nutritional Supplements. New Star Publishing. Los Angeles. 1998.
Andress DL. Vannatta JB. Whang R. Treatment of refractory hypophosphatemia. Southern Medical Journal. 75(6):766-7, 1982 Jun.
Asch L. [Current treatment of common osteoporosis]. [French] Therapeutique. 48(5):399-401, 1972 May-Jun.
Berndt G. [Phosphorous and the prevention of dental caries]. [German] Deutsches Medizinisches Journal. 18(2):29-30, 1967 Jan 20.
Bordier P. Kuntz D. Miravet L. Marie P. [Treatment of ordinary osteoporosis by the combination of salmon calcitonin-phosphorus and magnesium (letter)]. [French] Nouvelle Presse Medicale. 8(6):444, 1979 Feb 3.
Broadus AE. Magee JS. Mallette LE. Horst RL. Lang R. Jensen PS. Gertner JM. Baron R. A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism. Journal of Clinical Endocrinology & Metabolism. 56(5):953-61, 1983 May.
Cantatore FP. Carrozzo M. Magli DM. D'Amore M. Pipitone V. Evaluation of mineral metabolism and bone turnover in osteoporotic females treated with phosphorus and salmon calcitonin. Clinical Rheumatology. 6(4):504-9, 1987 Dec
Chapuy P. Cibert M. [Phosphorus in therapeutics]. [French] Lyon Medical. 226(20):883-9, 1971 Dec 26.
Dard S. Ulmann A. [Compared metabolic effects of phosphorus or hydrochlorothiazide therapy in hypercalciuric stone-formers (author's transl)]. [French] Nephrologie. 2(1):4-7, 1981.
Dumas R. Guermoud C. Garabedian M. Meunier JP. [Biological and bone histomorphometric studies in hypophosphatemic vitamin-resistant rickets treated with 1,25-(OH)2D and phosphorus]. [French] Archives Francaises de Pediatrie. 42(7):507-10, 1985 Aug-Sep.
Eisinger J. D'Omezon Y. Laponche AM. Recordier AM. [Current trends of phosphotherapy. [French] Marseille Medical. 109(4):261-3, 1972.
Eisinger J. Omezon Y d'. Salvo A. [Current trends in phosphotherapy. V. Urinary acidity and phosphorus]. [French] Marseille Medical. 108(9):608-10, 1971.
Eisinger J. Omezon Y d'. Recordier AM. [Current trends in phosphotherapy. IV. Treatment of oxalic lithiasis]. [French] Marseille Medical. 108(9):605-8, 1971.
Flot F. Ballon G. [Effect of phosphorus intake in the treatment of maxillofacial fractures]. [French] Annales de Chirurgie. 26(23):1245-7, 1972 Nov.
Friedman NE. Lobaugh B. Drezner MK. Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia. Journal of Clinical Endocrinology & Metabolism. 76(4):839-44, 1993 Apr
Godard C. Royer P. [Therapeutic uses of phosphorus. Review of literature]. [Review] [53 refs] [French] Therapeutique. 47(8):717-23, 1971 Oct.
Guibaud P. Larbre F. [A case of benign hypophosphatasia treated with phosphorus]. [French] Pediatrie. 25(3):319-30, 1970 Apr-May.
Hantman DA. Vogel JM. Donaldson CL. Friedman R. Goldsmith RS. Hulley SB. Attempts to prevent disuse osteoporosis by treatment with calcitonin, longitudinal compression and supplementary calcium and phosphate. Journal of Clinical Endocrinology & Metabolism. 36(5):845-58, 1973 May.
Harrell RM. Lyles KW. Harrelson JM. Friedman NE. Drezner MK. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. Journal of Clinical Investigation. 75(6):1858-68, 1985 Jun.
Heaney, RP. Bone and Mineral Research, Vol. 4. Elsevier: New York. 1986. pp. 255-301.
Krause MV and LK Mahan. Food, Nutrition, and Diet Therapy, 5th edition. Philadelphia: WB Saunders. 1984.
Laing IA. Glass EJ. Hendry GM. Westwood A. Elton RA. Lang M. Hume R. Rickets of prematurity: calcium and phosphorus supplementation. Journal of Pediatrics. 106(2):265-8, 1985 Feb. 85107462
Lyles KW. Harrelson JM. Drezner MK. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia. Journal of Clinical Endocrinology & Metabolism. 54(2):307-15, 1982 Feb.
Murray M and J Pizzorno. Encyclopedia of Narural Medicine, 2nd edition. Rocklin, Calif: Prima Publishing, 1996.
Narbouton R. Voyer M. Charlas J. [Value of a phosphorus supplemented formula for premature infants]. [French] Annales de Pediatrie. 36(10):703-6, 1989 Dec.
Pickard DW. An apparent reduction in the incidence of milk fever achieved by regulation of the dietary intake of calcium and phosphorus. British Veterinary Journal. 131(6):744-5, 1975 Nov-Dec.
Popovtzer MM. Stjernholm M. Huffer WE. Effects of alternating phosphorus and calcium infusions on osteoporosis. American Journal of Medicine. 61(4):478-84, 1976 Oct.
Powers JC. Herbsman H. Hirschman A. Shaftan GW. Phosphate supplements in experimental fractures. Journal of Surgical Research. 8(9):411-6, 1968 Sep.
Prestridge LL. Schanler RJ. Shulman RJ. Burns PA. Laine LL. Effect of parenteral calcium and phosphorus therapy on mineral retention and bone mineral content in very low birth weight infants. Journal of Pediatrics. 122(5 Pt 1):761-8, 1993 May.
Recordier AM. D'Omezon Y. Eisinger J. [Current trends of phosphotherapy. VII. Conclusion]. [French] Marseille Medical. 109(4):265, 1972.
Recordier AM. Eisinger J. [Current trends of phosphotherapy]. [French] Marseille Medical. 107(11):873-7, 1970.
Renier JC. Boasson M. Jallet P. [A case of vitamin-resistant hypophosphoremic osteomalacia in an adult: effect of thyrocalcitonin and course under vitamin-phosphorus treatment]. [French] Rhumatologie. 24(7):247-56, 1972 Aug-Sep.
Schauss, A. Minerals, Trace Elements and Human Health, 4th edition. Biosocial Publications: Tacoma, WA. 1999.
Schmidt H. [Calcium and phosphorus salts in caries prevention]. [German] Deutsche Stomatologie (Berlin). 21(2):150-4, 1971 Feb.
Ulmann A. Hadj S. Lacour B. Bourdeau A. Bader C. Renal magnesium and phosphate wastage in a patient with hypercalciuria and nephrocalcinosis: effect of oral phosphorus and magnesium supplements. Nephron. 40(1):83-7, 1985.
Zhou ZG. Wu HW. Chao CS. [Erythrocyte 2,3-diphosphoglycerate changes and the effect of phosphate supplement in diabetics]. [Chinese] Chung-Hua Nei Ko Tsa Chih Chinese Journal of Internal Medicine. 27(3):147-9, 196, 1988 Mar.
|
